Trendlines Medical Singapore

Trendlines teams up with Ozi Amanat as Startup SG Equity co-investors

SINGAPORE (Feb 8): Trendlines Medical Singapore, a subsidiary of Israeli company The Trendlines Group, is partnering Singapore-based investor Ozi Amanat’s venture capital firm, K2 Global, to collaborate in SPRING SEEDS Capital’s (SSC) $100 million investment allocation via the Startup SG Equity scheme.

Under the Startup SG Equity scheme, SSC supports early-stage startups across the technology and industry domain areas, and catalyses private-sector investments for startups via government equity co-investment.

Trendlines reports near-doubling of 3Q earnings to $4.1 mil on fair value gains

SINGAPORE (Nov 9): The Trendlines Group saw its earnings for 3Q17 nearly double to US$3 million ($4.1 million) from US$1.6 million a year ago on higher total income due to fair value gains.

Total income for the Israel based, Catalist listed group grew 65.7% over the quarter to US$6.8 million from US$4.1 million in the previous year.

The growth in total income was mainly attributable to an eightfold growth in its gain from changes in fair value of investments in portfolio companies to US$5.3 million as compared to US$0.6 million a year ago.

Trendlines Medical makes maiden investment in medical device startup

SINGAPORE (Oct 16): Trendlines Medical Singapore, a 76.43%-owned subsidiary of Catalist-listed Israeli company The Trendlines Group, has made its first investment by committing a total of US$60,000 ($81,150) to a medical device start-up, InterVaal.

InterVaal is developing a urological catheter to address catheter associated urinary tract infection.

Trendlines says that its in-house innovation unit, Trendlines Labs, will work with InterVaal’s Singapore-based staff to develop the catheter and conduct clinical trials in Singapore.

Trendlines sees itself as more than just a venture firm

SINGAPORE (April 11): Trendlines Group, the incubator for medical and agri-tech companies, aims to increase its number of portfolio companies, build value in these companies, expand into new markets as well as grow Trendlines Labs.

Trendlines recently hosted a site visit to Tel Aviv, Israel, in which OCBC analysts were among the those invited. The trip included the group’s 7th Annual Trendlines Company Showcase, whereby selected companies under Trendlines presented their innovations.

Trendlines Medical Singapore to hold opening ceremony on Feb 22

SINGAPORE (Feb 1): Trendlines Medical Singapore, the medical incubator subsidiary of Israeli firm Trendlines Group, will hold its official opening ceremony on Feb 22 at its office located at Launchpad @One North.

The group will also release its financial results for FY16 on the same day before the market opens, followed by a conference call held by its management for analysts and investors at 1pm that day.

Trendlines Medical Singapore to get grant of up to $2.2 mil from SPRING Singapore

SINGAPORE (Jan 16): Trendlines Medical Singapore, the medical incubator subsidiary of Israeli firm Trendlines Group, will receive a grant of up to $2.2 million under SPRING Singapore’s Incubator Development Program.

SPRING Singapore is the enterprise development agency of the Singapore Ministry of Trade and Industry.

The program provides grant support to incubators to enhance their capabilities and programs to assist start-ups, and will support up to 70% of a company’s expenditures incurred (amounting to no more than $2.2 million) over a three-year period.

B.Braun acquires 20.74% stake in Trendlines Medical Singapore

SINGAPORE (Dec 21): Trendlines Group has entered an agreement with B. Braun, the German medical device company, for the latter to become a 20.74% minority shareholder in the group’s wholly-owned subsidiary, Trendlines Medical Singapore.

Trendlines will remain the majority shareholder holding the remaining 79.26% stake in the company, which is valued at $2.5 million.

Be informed of the stories that matter